Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million
Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million
Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million